DUBLIN, July 9, 2021 /PRNewswire/ — The “United States Diagnostics Market, By Product Type (Reagents, Instruments, Software & Services), By Type of Test (Infectious Disease Testing, Lipid Panel, Others), By Technique, By Usability, By Application, By End User, By Region, Competition Forecast & Opportunities, 2026” report has been added to ResearchAndMarkets.com’s offering.
The United States Diagnostics Market stood at USD30.08billion in 2020 and is expected to grow at a steady rate of 5.17% during the forecast period.
The United States Diagnostics Market is driven by the growing prevalence of various chronic and infectious diseases. Additionally, increasing awareness among the population pertaining to healthcare is further expected to propel the market growth. Besides, supportive government policies & schemes such as Patient Protection & Affordable Care Act, Medicare and Medicaid are further expected to positively influence the market growth through 2026.
Furthermore, increasing investment on R&D and new product or instruments/techniques launches by the major players is expected to create lucrative opportunities for the market growth over the next few years. Moreover, the sudden outbreak and spread of pandemic COVID-19 within the country has drastically increased the demand for infectious disease testing diagnostic tests and procedures being carried out. It has also increased the demand for rapid test kits which can help in the diagnosis of disease, thereby fueling the…
